Raymond James Financial
CTSO icon

Raymond James Financial’s Cytosorbents Corp CTSO Stock Holding History

Raymond James Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.2K Sell
5,381
-7
-0.1% -$74 ﹤0.01% 5281
2026
Q1 		$61K Sell
5,388
-47
-0.9% -$642 ﹤0.01% 5098
2025
Q4 		$69.5K Sell
5,435
-1
-0% -$15 ﹤0.01% 4976
2025
Q3 		$102K Buy
5,436
+7
+0.1% +$138 ﹤0.01% 4748
2025
Q2 		$139K Sell
5,429
-88
-2% -$1.77K ﹤0.01% 4703
2025
Q1 		$110K Buy
5,517
+86
+2% +$1.81K ﹤0.01% 4534
2024
Q4 		$98.8K Buy
+5,431
New +$107K ﹤0.01% 4530

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Raymond James Financial's CTSO Position: Q2 2026 in Review

Raymond James Financial reduced its Cytosorbents Corp (CTSO) stake by 0.13% in Q2 2026, selling an estimated $74 and leaving 5,381 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5281.

Raymond James Financial first reported a position in CTSO in Q4 2024 and has held it in 7 quarters since. The position peaked at $139K in Q2 2025. 47 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Raymond James Financial held 5,381 shares of Cytosorbents Corp worth $40.2K as of Q2 2026.
  • Raymond James Financial sold 7 Cytosorbents Corp shares in Q2 2026, an estimated $74.
  • Cytosorbents Corp made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5281 holding.
  • Raymond James Financial first reported a position in Cytosorbents Corp in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Cytosorbents Corp position peaked at $139K in Q2 2025.
  • 47 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.